Literature DB >> 10419876

Adeno-associated virus vectors and hematology.

D W Russell1, M A Kay.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10419876      PMCID： PMC3739711     

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  130 in total

1.  Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction.

Authors:  G Fisher-Adams; K K Wong; G Podsakoff; S J Forman; S Chatterjee
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

2.  Adeno-associated virus vector integration junctions.

Authors:  E A Rutledge; D W Russell
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Type C retrovirus inactivation by human complement is determined by both the viral genome and the producer cell.

Authors:  Y Takeuchi; F L Cosset; P J Lachmann; H Okada; R A Weiss; M K Collins
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

4.  Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo.

Authors:  K Qing; B Khuntirat; C Mah; D M Kube; X S Wang; S Ponnazhagan; S Zhou; V J Dwarki; M C Yoder; A Srivastava
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy.

Authors:  M Le; T Okuyama; S R Cai; S C Kennedy; W M Bowling; M W Flye; K P Ponder
Journal:  Blood       Date:  1997-02-15       Impact factor: 22.113

6.  Recombinant adenoviruses with large deletions generated by Cre-mediated excision exhibit different biological properties compared with first-generation vectors in vitro and in vivo.

Authors:  A Lieber; C Y He; I Kirillova; M A Kay
Journal:  J Virol       Date:  1996-12       Impact factor: 5.103

7.  Complete short-term correction of canine hemophilia A by in vivo gene therapy.

Authors:  S Connelly; J Mount; A Mauser; J M Gardner; M Kaleko; A McClelland; C D Lothrop
Journal:  Blood       Date:  1996-11-15       Impact factor: 22.113

8.  Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2.

Authors:  E A Rutledge; C L Halbert; D W Russell
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.

Authors:  P L Hermonat; N Muzyczka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

Review 10.  Problems and prospects in gene therapy for hemophilia.

Authors:  R W Herzog; K A High
Journal:  Curr Opin Hematol       Date:  1998-09       Impact factor: 3.284
View more
  16 in total

1.  Kinetics of recombinant adeno-associated virus-mediated gene transfer.

Authors:  A K Malik; P E Monahan; D L Allen; B G Chen; R J Samulski; K Kurachi
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Hematopoietic stem cell gene therapy.

Authors:  David W Emery; Tamon Nishino; Ken Murata; Michalis Fragkos; George Stamatoyannopoulos
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

3.  Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo.

Authors:  H Nakai; T A Storm; M A Kay
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 4.  Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction.

Authors:  Vincent Hurez; Robin D Hautton; James Oliver; R James Matthews; Casey K Weaver
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

5.  Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks.

Authors:  Matthew H Porteus; Toni Cathomen; Matthew D Weitzman; David Baltimore
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

6.  Induced pluripotent stem cell clones reprogrammed via recombinant adeno-associated virus-mediated transduction contain integrated vector sequences.

Authors:  J Weltner; A Anisimov; K Alitalo; T Otonkoski; R Trokovic
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

7.  Targeted integration of foreign DNA into a defined locus on chromosome 19 in K562 cells using AAV-derived components.

Authors:  Katsuhiro Kogure; Masashi Urabe; Hiroaki Mizukami; Akihiro Kume; Yuko Sato; John Monahan; Keiya Ozawa
Journal:  Int J Hematol       Date:  2001-06       Impact factor: 2.490

8.  Viral transduction of male germline stem cells results in transgene transmission after germ cell transplantation in pigs.

Authors:  Wenxian Zeng; Lin Tang; Alla Bondareva; Ali Honaramooz; Valeria Tanco; Camila Dores; Susan Megee; Mark Modelski; Jose Rafael Rodriguez-Sosa; Melissa Paczkowski; Elena Silva; Matt Wheeler; Rebecca L Krisher; Ina Dobrinski
Journal:  Biol Reprod       Date:  2013-01-31       Impact factor: 4.285

Review 9.  Adeno-associated virus vector integration.

Authors:  David R Deyle; David W Russell
Journal:  Curr Opin Mol Ther       Date:  2009-08

Review 10.  Theodore E. Woodward Award. AAV-mediated gene transfer for hemophilia.

Authors:  Katherine A High
Journal:  Trans Am Clin Climatol Assoc       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.